Extracts of a document from Medicines and Healthcare products Regulatory Agency, titled Conditions for Authorisation for Emergency Supply under Regulation 174 for COVID-19 Vaccine AstraZeneca, undated.
Module 4 adduced:
• Pages 3 and 4 on 23 January 2025